Current Volume 13(3) 2008 (9)

08 Sep 2008
How Iran could maintain its peak of transplantation publication?
Shervin Assari,
Ann Transplant 2008; 13(3): 48-49 :: ID: 868539

08 Sep 2008
How Iran could maintain its peak of transplantation publication?
Shervin Assari
Ann Transplant 2008; 13(3): 48-49 :: ID: 868539
926

19 Sep 2008
Immunogenicity of pneumococcal vaccination in renal transplant recipients and hemodialysis patients: A comparative controlled trial
Vahid Pourfarziani, Mohammad Bagher Ramezani
Ann Transplant 2008; 13(3): 43-47 :: ID: 868538

19 Sep 2008
Immunogenicity of pneumococcal vaccination in renal transplant recipients and hemodialysis patients: A comparative controlled trial
Vahid Pourfarziani, Mohammad Bagher Ramezani, Saeed Taheri, Morteza Izadi, Behzad Einollahi
Ann Transplant 2008; 13(3): 43-47 :: ID: 868538
1,039

19 Sep 2008
Mayo risk score for primary biliary cirrhosis: A useful tool for the prediction of course after liver transplantation?
Dietmar A. Jacob, Marcus Bahra
Ann Transplant 2008; 13(3): 35-42 :: ID: 868537

19 Sep 2008
Mayo risk score for primary biliary cirrhosis: A useful tool for the prediction of course after liver transplantation?
Dietmar A. Jacob, Marcus Bahra, Sven C. Schmidt, Guido Schumacher, Andreas Weimann, Peter Neuhaus, Ulf P. Neumann
Ann Transplant 2008; 13(3): 35-42 :: ID: 868537
1,887

19 Sep 2008
Per-operative changes and related factors during simultaneous pancreas-kidney transplantation: First experience at a Brazilian University Hospital
Adriana de Castro Carvalho Faria, Eduardo Costa Teixeira
Ann Transplant 2008; 13(3): 30-34 :: ID: 868536

19 Sep 2008
Per-operative changes and related factors during simultaneous pancreas-kidney transplantation: First experience at a Brazilian University Hospital
Adriana de Castro Carvalho Faria, Eduardo Costa Teixeira, Felipe Oliveira de Faria, José Marcus Raso Eulálio, Louis Barrucand, Nubia Verçosa
Ann Transplant 2008; 13(3): 30-34 :: ID: 868536
657

08 Sep 2008
Outcome of heart transplantations done in our centre
Ji-ming Sha, Yi-qin Tao
Ann Transplant 2008; 13(3): 27-29 :: ID: 868535

08 Sep 2008
Outcome of heart transplantations done in our centre
Ji-ming Sha, Yi-qin Tao, Dao-hang Li, Hai-feng Hu
Ann Transplant 2008; 13(3): 27-29 :: ID: 868535
665

19 Sep 2008
Laparoscopic live-donor nephrectomy with retroperitoneoscopic access – first case experience
Marcin Słojewski, Tomasz Śluzar
Ann Transplant 2008; 13(3): 23-26 :: ID: 868534

19 Sep 2008
Laparoscopic live-donor nephrectomy with retroperitoneoscopic access – first case experience
Marcin Słojewski, Tomasz Śluzar, Adam Gołąb, Jerzy Chłodny, Samir Zeair, Krzysztof Dziewanowski, Marek Umiński, Andrzej Sikorski
Ann Transplant 2008; 13(3): 23-26 :: ID: 868534
1,037

19 Sep 2008
Successful open pulmonary embolectomy for acute massive pulmonary embolism in a recent kidney transplant recipient
Patrick P. McHugh, Thomas D. Johnston
Ann Transplant 2008; 13(3): 19-22 :: ID: 868533

19 Sep 2008
Successful open pulmonary embolectomy for acute massive pulmonary embolism in a recent kidney transplant recipient
Patrick P. McHugh, Thomas D. Johnston, Roberto Gedaly, Hoonbae Jeon, Dinesh Ranjan
Ann Transplant 2008; 13(3): 19-22 :: ID: 868533
1,142

19 Sep 2008
Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring
Dirk R. Kuypers,
Ann Transplant 2008; 13(3): 11-18 :: ID: 868532

19 Sep 2008
Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring
Dirk R. Kuypers
Ann Transplant 2008; 13(3): 11-18 :: ID: 868532
1,277

19 Sep 2008
Pharmacokinetic principles of immunosuppressive drugs
Klemens Budde, Petra Glander
Ann Transplant 2008; 13(3): 5-10 :: ID: 868531

19 Sep 2008
Pharmacokinetic principles of immunosuppressive drugs
Klemens Budde, Petra Glander
Ann Transplant 2008; 13(3): 5-10 :: ID: 868531
1,152
Volume 13(3) 2008 (9) Supplement

01 Jan 2008 :
Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers
Z. Marchewka, J. Kuźniar
Ann Transplant 2008; 13(1): 43-43 :: ID: 880211
537 0

01 Jan 2008 :
Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers
Z. Marchewka, J. Kuźniar, K. Falkiewicz, B. Szymańska, M. Zynek-Litwin, D. Patrzałek, A. Długosz, M. Klinger
Ann Transplant 2008; 13(1): 43-43 :: ID: 880211
537 0

01 Jan 2008 :
Drug lymphocyte level: New perspective in clinical immunosuppression monitoring
A. Barbari,
Ann Transplant 2008; 13(1): 43-43 :: ID: 880210
477 0

01 Jan 2008 :
Drug lymphocyte level: New perspective in clinical immunosuppression monitoring
A. Barbari
Ann Transplant 2008; 13(1): 43-43 :: ID: 880210
477 0

01 Jan 2008 :
Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation
J. M. Kovarik, K. Budde
Ann Transplant 2008; 13(1): 42-42 :: ID: 880209
515 0

01 Jan 2008 :
Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation
J. M. Kovarik, K. Budde, J. Steiger, J. M. Grinyo, F. Straube, A. Groenewegen, A. Vitalit, J. Geissler, J. Klupp, M. J. Barten
Ann Transplant 2008; 13(1): 42-42 :: ID: 880209
515 0

01 Jan 2008 :
Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration
L. R. Chiarelli, M. Molinaro
Ann Transplant 2008; 13(1): 42-42 :: ID: 880208
511 0

01 Jan 2008 :
Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration
L. R. Chiarelli, M. Molinaro, C. Libetta, C. Tinelli, L. Cosmai, G. Valentini, A. Dal Canton, M. Regazzi
Ann Transplant 2008; 13(1): 42-42 :: ID: 880208
511 0

01 Jan 2008 :
IMPDH activity on day 6 after kidney transplantation is signiï¬cantly related to the risk of acute rejection in MMF treated patients
F. Sombogaard, R.A.A. Mathot
Ann Transplant 2008; 13(1): 41-42 :: ID: 880207
512 0

01 Jan 2008 :
IMPDH activity on day 6 after kidney transplantation is signiï¬cantly related to the risk of acute rejection in MMF treated patients
F. Sombogaard, R.A.A. Mathot, P. Glander, W. Weimar, T. van Gelder
Ann Transplant 2008; 13(1): 41-42 :: ID: 880207
512 0

01 Jan 2008 :
Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)
E. Wieland, M. Shipkova
Ann Transplant 2008; 13(1): 41-41 :: ID: 880206
482 0

01 Jan 2008 :
Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)
E. Wieland, M. Shipkova, Y. Martius, G. Hasche, C. Klett, R. Bolley, C. Olbricht
Ann Transplant 2008; 13(1): 41-41 :: ID: 880206
482 0

01 Jan 2008 :
Tacrolimus – biotechnological prospects for a generic product
W. Gajzlerska, J. Turło
Ann Transplant 2008; 13(1): 40-41 :: ID: 880205
447 0

01 Jan 2008 :
Tacrolimus – biotechnological prospects for a generic product
W. Gajzlerska, J. Turło, B. Gutkowska, F. Herold
Ann Transplant 2008; 13(1): 40-41 :: ID: 880205
447 0

01 Jan 2008 :
Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufï¬ciency
M. Chrzanowska, J. Kamińska
Ann Transplant 2008; 13(1): 40-40 :: ID: 880204
447 0

01 Jan 2008 :
Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufï¬ciency
M. Chrzanowska, J. Kamińska, M. Głyda, N. Wachowiak
Ann Transplant 2008; 13(1): 40-40 :: ID: 880204
447 0

01 Jan 2008 :
Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?
H. Tesfaye, R. Prusa
Ann Transplant 2008; 13(1): 40-40 :: ID: 880203
457 0

01 Jan 2008 :
Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?
H. Tesfaye, R. Prusa, B. Jedlickova, J. Segethova
Ann Transplant 2008; 13(1): 40-40 :: ID: 880203
457 0

01 Jan 2008 :
Therapeutic Drug Monitoring of tacrolimus in renal transplant patients
B. Solnica, K. Słowińska-Solnica
Ann Transplant 2008; 13(1): 39-40 :: ID: 880202
469 0

01 Jan 2008 :
Therapeutic Drug Monitoring of tacrolimus in renal transplant patients
B. Solnica, K. Słowińska-Solnica, E. Ignacak, J. W. Naskalski
Ann Transplant 2008; 13(1): 39-40 :: ID: 880202
469 0

01 Jan 2008 :
Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool
J.E. Wallin, L. E. Friberg
Ann Transplant 2008; 13(1): 39-39 :: ID: 880201
462 0

01 Jan 2008 :
Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool
J.E. Wallin, L. E. Friberg, A. Fasth, C. E. Staatz
Ann Transplant 2008; 13(1): 39-39 :: ID: 880201
462 0

01 Jan 2008 :
Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients
D. Kamińska, M. Kuriata-Kordek
Ann Transplant 2008; 13(1): 38-39 :: ID: 880200
611 0

01 Jan 2008 :
Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients
D. Kamińska, M. Kuriata-Kordek, M. Boratyńska, K. Falkiewicz, M. Klinger
Ann Transplant 2008; 13(1): 38-39 :: ID: 880200
611 0

01 Jan 2008 :
Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation
C. Seger, M. Bock
Ann Transplant 2008; 13(1): 38-38 :: ID: 880198
448 0

01 Jan 2008 :
Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation
C. Seger, M. Bock, K. Tentschert, A. Griesmacher
Ann Transplant 2008; 13(1): 38-38 :: ID: 880198
448 0

01 Jan 2008 :
Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)
M. T. Rabuñal Ãlvarez, E. Fernández Gabriel
Ann Transplant 2008; 13(1): 38-38 :: ID: 880199
454 0

01 Jan 2008 :
Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)
M. T. Rabuñal Ãlvarez, E. Fernández Gabriel, M. Outeda MacÃas, I. MartÃn Herranz
Ann Transplant 2008; 13(1): 38-38 :: ID: 880199
454 0

01 Jan 2008 :
Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays
P. Wallemacq, J. S. Gofï¬net
Ann Transplant 2008; 13(1): 37-38 :: ID: 880197
498 0

01 Jan 2008 :
Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays
P. Wallemacq, J. S. Gofï¬net, H. Ait-Youcef
Ann Transplant 2008; 13(1): 37-38 :: ID: 880197
498 0

01 Jan 2008 :
Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions
T. Wei, N. Morjana
Ann Transplant 2008; 13(1): 37-37 :: ID: 880196
498 0

01 Jan 2008 :
Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions
T. Wei, N. Morjana, S. Goss, L. Bantum, Y. Yue, R. Janzen, G. Siefring
Ann Transplant 2008; 13(1): 37-37 :: ID: 880196
498 0

01 Jan 2008 :
Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology
A. M. Taylor, T. N. Gamble
Ann Transplant 2008; 13(1): 36-37 :: ID: 880195
503 0

01 Jan 2008 :
Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology
A. M. Taylor, T. N. Gamble, D. Blake, T. Drury, M. Ehrdhard
Ann Transplant 2008; 13(1): 36-37 :: ID: 880195
503 0

01 Jan 2008 :
High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system
R. Ruzicka, M. Kozak
Ann Transplant 2008; 13(1): 36-36 :: ID: 880194
475 0

01 Jan 2008 :
High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system
R. Ruzicka, M. Kozak, V. Bodepudi, R. Loor, J. Zonderman
Ann Transplant 2008; 13(1): 36-36 :: ID: 880194
475 0

01 Jan 2008 :
Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles
N. W. Brown, P. Arampatzis
Ann Transplant 2008; 13(1): 36-36 :: ID: 880193
533 0

01 Jan 2008 :
Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles
N. W. Brown, P. Arampatzis, C. E. Gonde, M. Pires, J. Tracey, M. Tredger
Ann Transplant 2008; 13(1): 36-36 :: ID: 880193
533 0

29 Sep 2008 :
The role of genetics and pharmacogenetic monitoring in transplantation
M. Masri,
Ann Transplant 2008; 13(1): 35-35 :: ID: 880192
488 0

29 Sep 2008 :
The role of genetics and pharmacogenetic monitoring in transplantation
M. Masri
Ann Transplant 2008; 13(1): 35-35 :: ID: 880192
488 0

01 Jan 2008 :
The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients
H. de Jonge, M. Naesens
Ann Transplant 2008; 13(1): 34-35 :: ID: 880191
484 0

01 Jan 2008 :
The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients
H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers
Ann Transplant 2008; 13(1): 34-35 :: ID: 880191
484 0

01 Jan 2008 :
In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay
R.l Kato, M. Nishide
Ann Transplant 2008; 13(1): 34-34 :: ID: 880190
524 0

01 Jan 2008 :
In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay
R.l Kato, M. Nishide, C. Kodzu, Y. Ijiri, K. Tanaka
Ann Transplant 2008; 13(1): 34-34 :: ID: 880190
524 0

01 Jan 2008 :
In vivo hepatic CYP3A4 activity is signiï¬cantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients
H. de Jonge, M. Naesens
Ann Transplant 2008; 13(1): 34-34 :: ID: 880189
494 0

01 Jan 2008 :
In vivo hepatic CYP3A4 activity is signiï¬cantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients
H. de Jonge, M. Naesens, K. Verbeke, Y. Vanrenterghem, D. R. Kuypers
Ann Transplant 2008; 13(1): 34-34 :: ID: 880189
494 0

01 Jan 2008 :
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients
A. Provenzani, M. Notarbartolo
Ann Transplant 2008; 13(1): 33-33 :: ID: 880188
455 0

01 Jan 2008 :
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients
A. Provenzani, M. Notarbartolo, F. Biondi, M. Labbozzetta, P. Poma, G. Vizzini, U. Palazzo, P. Polidori, F. Triolo, B. Gridelli, N. D'Alessandro
Ann Transplant 2008; 13(1): 33-33 :: ID: 880188
455 0

01 Jan 2008 :
The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients
H. de Jonge, M. Naesens
Ann Transplant 2008; 13(1): 33-33 :: ID: 880187
593 0

01 Jan 2008 :
The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients
H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers
Ann Transplant 2008; 13(1): 33-33 :: ID: 880187
593 0

01 Jan 2008 :
Modiï¬ed release formulation in immunotherapy – the tacrolimus case
N. Undre,
Ann Transplant 2008; 13(1): 32-32 :: ID: 880186
474 0

01 Jan 2008 :
Modiï¬ed release formulation in immunotherapy – the tacrolimus case
N. Undre
Ann Transplant 2008; 13(1): 32-32 :: ID: 880186
474 0

01 Jan 2008 :
Generic substitution of immunosuppressive drugs – requirements for an equivalent product
A. Johnston, D. W. Holt
Ann Transplant 2008; 13(1): 31-31 :: ID: 880185
442 0

01 Jan 2008 :
Generic substitution of immunosuppressive drugs – requirements for an equivalent product
A. Johnston, D. W. Holt
Ann Transplant 2008; 13(1): 31-31 :: ID: 880185
442 0

01 Jan 2008 :
Generic products – requirements for drug registration
P. K. Kunicki,
Ann Transplant 2008; 13(1): 30-30 :: ID: 880184
400 0

01 Jan 2008 :
Generic products – requirements for drug registration
P. K. Kunicki
Ann Transplant 2008; 13(1): 30-30 :: ID: 880184
400 0

01 Jan 2008 :
Therapeutic drug monitoring of immunosuppressive drugs – future perspectives
P. Wallemacq,
Ann Transplant 2008; 13(1): 29-29 :: ID: 880183
412 0

01 Jan 2008 :
Therapeutic drug monitoring of immunosuppressive drugs – future perspectives
P. Wallemacq
Ann Transplant 2008; 13(1): 29-29 :: ID: 880183
412 0

01 Jan 2008 :
Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring
D. R. Kuypers,
Ann Transplant 2008; 13(1): 28-28 :: ID: 880182
436 0

01 Jan 2008 :
Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring
D. R. Kuypers
Ann Transplant 2008; 13(1): 28-28 :: ID: 880182
436 0

01 Jan 2008 :
Pharmacokinetics of mycophenolic acid: A comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients
T. van Gelde,
Ann Transplant 2008; 13(1): 27-27 :: ID: 880181
481 0

01 Jan 2008 :
Pharmacokinetics of mycophenolic acid: A comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients
T. van Gelde
Ann Transplant 2008; 13(1): 27-27 :: ID: 880181
481 0

01 Jan 2008 :
Therapeutic drug monitoring of sirolimus and everolimus
E.M. Billaud,
Ann Transplant 2008; 13(1): 26-26 :: ID: 880180
433 0

01 Jan 2008 :
Therapeutic drug monitoring of sirolimus and everolimus
E.M. Billaud
Ann Transplant 2008; 13(1): 26-26 :: ID: 880180
433 0

01 Jan 2008 :
Therapeutic drug monitoring of tacrolimus
P. Wallemacq,
Ann Transplant 2008; 13(1): 25-25 :: ID: 880179
427 0

01 Jan 2008 :
Therapeutic drug monitoring of tacrolimus
P. Wallemacq
Ann Transplant 2008; 13(1): 25-25 :: ID: 880179
427 0

01 Jan 2008 :
Therapeutic drug monitoring of ciclosporin
A. Johnston, D. W. Holt
Ann Transplant 2008; 13(1): 24-24 :: ID: 880178
469 0

01 Jan 2008 :
Therapeutic drug monitoring of ciclosporin
A. Johnston, D. W. Holt
Ann Transplant 2008; 13(1): 24-24 :: ID: 880178
469 0

01 Jan 2008 :
Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the curve in patients receiving concomitant sirolimus or cyclosporine
L. M. Shaw, M. Figurski
Ann Transplant 2008; 13(1): 23-23 :: ID: 880177
403 0

01 Jan 2008 :
Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the curve in patients receiving concomitant sirolimus or cyclosporine
L. M. Shaw, M. Figurski, M. D. Pescovitz
Ann Transplant 2008; 13(1): 23-23 :: ID: 880177
403 0

01 Jan 2008 :
Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs
P. Marquet,
Ann Transplant 2008; 13(1): 22-22 :: ID: 880176
486 0

01 Jan 2008 :
Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs
P. Marquet
Ann Transplant 2008; 13(1): 22-22 :: ID: 880176
486 0

01 Jan 2008 :
What can we learn from proï¬ciency testing of immunosuppressive drug assays?
D. W. Holt, A. Johnston
Ann Transplant 2008; 13(1): 21-21 :: ID: 880175
404 0

01 Jan 2008 :
What can we learn from proï¬ciency testing of immunosuppressive drug assays?
D. W. Holt, A. Johnston
Ann Transplant 2008; 13(1): 21-21 :: ID: 880175
404 0

01 Jan 2008 :
Immunoassays for immunosuppressive drugs – beneï¬ ts and risks
W. Steimer,
Ann Transplant 2008; 13(1): 20-20 :: ID: 880174
518 0

01 Jan 2008 :
Immunoassays for immunosuppressive drugs – beneï¬ ts and risks
W. Steimer
Ann Transplant 2008; 13(1): 20-20 :: ID: 880174
518 0

01 Jan 2008 :
Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice
M. Korecka,
Ann Transplant 2008; 13(1): 19-19 :: ID: 880173
415 0

01 Jan 2008 :
Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice
M. Korecka
Ann Transplant 2008; 13(1): 19-19 :: ID: 880173
415 0

01 Jan 2008 :
Introduction to high-performance liquid chromatography-tandem mass spectrometry: The gold standard for monitoring immunosuppressive drugs
P. J. Taylor,
Ann Transplant 2008; 13(1): 18-18 :: ID: 880172
772 0

01 Jan 2008 :
Introduction to high-performance liquid chromatography-tandem mass spectrometry: The gold standard for monitoring immunosuppressive drugs
P. J. Taylor
Ann Transplant 2008; 13(1): 18-18 :: ID: 880172
772 0

01 Jan 2008 :
Biomarkers - as an adjunct to immunosuppressive drug monitoring
M. Oellerich,
Ann Transplant 2008; 13(1): 17-17 :: ID: 880171
489 0

01 Jan 2008 :
Biomarkers - as an adjunct to immunosuppressive drug monitoring
M. Oellerich
Ann Transplant 2008; 13(1): 17-17 :: ID: 880171
489 0

01 Jan 2008 :
PK/PD modelling of immunosuppressive agents
E. Wyska,
Ann Transplant 2008; 13(1): 16-16 :: ID: 880170
549 0

01 Jan 2008 :
PK/PD modelling of immunosuppressive agents
E. Wyska
Ann Transplant 2008; 13(1): 16-16 :: ID: 880170
549 0

01 Jan 2008 :
Drug transporters for immunosuppressive agents
I.A.M. MacPhee,
Ann Transplant 2008; 13(1): 15-15 :: ID: 880169
360 0

01 Jan 2008 :
Drug transporters for immunosuppressive agents
I.A.M. MacPhee
Ann Transplant 2008; 13(1): 15-15 :: ID: 880169
360 0

01 Jan 2008 :
Pharmacogenetics in immunotherapy: present knowledge and future perspectives
D. A. Hesselink,
Ann Transplant 2008; 13(1): 13-14 :: ID: 880168
566 0

01 Jan 2008 :
Pharmacogenetics in immunotherapy: present knowledge and future perspectives
D. A. Hesselink
Ann Transplant 2008; 13(1): 13-14 :: ID: 880168
566 0

01 Jan 2008 :
Pharmacokinetic principles of immunosuppressive-drugs
K. Budde, P. Glander
Ann Transplant 2008; 13(1): 12-12 :: ID: 880167
552 0

01 Jan 2008 :
Pharmacokinetic principles of immunosuppressive-drugs
K. Budde, P. Glander
Ann Transplant 2008; 13(1): 12-12 :: ID: 880167
552 0

01 Jan 2008 :
Clinical immunosuppression – current status
M. Klinger,
Ann Transplant 2008; 13(1): 11-11 :: ID: 880166
536 0

01 Jan 2008 :
Clinical immunosuppression – current status
M. Klinger
Ann Transplant 2008; 13(1): 11-11 :: ID: 880166
536 0

01 Jan 2008 :
New insight of immunosuppressive drugs related nephrotoxicity
E. Thervet,
Ann Transplant 2008; 13(1): 10-10 :: ID: 880165
504 0

01 Jan 2008 :
New insight of immunosuppressive drugs related nephrotoxicity
E. Thervet
Ann Transplant 2008; 13(1): 10-10 :: ID: 880165
504 0

01 Jan 2008 :
Organ transplantation in Poland
M. Durlik,
Ann Transplant 2008; 13(1): 9-9 :: ID: 880164
591 0

01 Jan 2008 :
Organ transplantation in Poland
M. Durlik
Ann Transplant 2008; 13(1): 9-9 :: ID: 880164
591 0
In Press
Original article
Retrospective Study to Compare Outcomes in 159 Patients Undergoing First Autologous Stem Cell Transplantati...Ann Transplant In Press; DOI: 10.12659/AOT.947186
Case report
Pulmonary Embolism Following Living Donor Hepatectomy: A Report of 4 Cases and Literature ReviewAnn Transplant In Press; DOI: 10.12659/AOT.946752
Most Viewed Current Articles
03 Jan 2023 : Original article 6,487
Impact of Autologous Stem Cell Transplantation on Primary Central Nervous System Lymphoma in First-Line and...DOI :10.12659/AOT.938467
Ann Transplant 2023; 28:e938467
16 May 2023 : Original article 6,127
Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections ...DOI :10.12659/AOT.939258
Ann Transplant 2023; 28:e939258
15 Aug 2023 : Review article 6,125
Free-Circulating Nucleic Acids as Biomarkers in Patients After Solid Organ TransplantationDOI :10.12659/AOT.939750
Ann Transplant 2023; 28:e939750
17 Jan 2023 : Original article 5,250
Non-Cryopreserved Peripheral Blood Stem Cell Graft for Autologous Hematopoietic Stem Cell Transplantation i...DOI :10.12659/AOT.938595
Ann Transplant 2023; 28:e938595